J
Jonathan A. Cooper
Researcher at Fred Hutchinson Cancer Research Center
Publications - 238
Citations - 35015
Jonathan A. Cooper is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: Phosphorylation & Proto-oncogene tyrosine-protein kinase Src. The author has an hindex of 92, co-authored 199 publications receiving 33998 citations. Previous affiliations of Jonathan A. Cooper include Salk Institute for Biological Studies & New York University.
Papers
More filters
Journal ArticleDOI
Mammalian Ras interacts directly with the serine/threonine kinase Raf
TL;DR: Raf interacts with wild-type and activated Ras, but not with an effector domain mutant of Ras or with a dominant-interfering Ras mutant, and this interaction is dependent on GTP bound to Ras.
Journal ArticleDOI
Regulation, substrates and functions of src.
TL;DR: This review focuses on developments in the last 6-7 years, and cites data resulting from the isolation and characterization of SRC mutants, crystallographic studies of the structures of SH2, SH3 and tyrosine kinase domains, biochemical studies of Src kinase activity and binding properties, and the biology of transgenic and knockout mouse strains.
Book ChapterDOI
Detection and quantification of phosphotyrosine in proteins.
TL;DR: This chapter discusses the detection and quantification of phosphotyrosine in proteins, and describes the kinases associated with the cell surface receptors for two polypeptide growth factors, epidermal growth factor and platelet-derived growth factor, and with the transforming proteins of at least five genetically distinct groups of retroviruses.
Journal ArticleDOI
Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2
Andrew J. Waskiewicz,Andrea Flynn,Christopher G. Proud,Jonathan A. Cooper,Jonathan A. Cooper +4 more
TL;DR: Mnk1 may define a convergence point between the growth factor‐activated and one of the stress‐activated protein kinase cascades and is a candidate to phosphorylate eIF‐4E in cells.